Biotech

RepliCel Announces Completion of First Injections in Clinical Trial of RCS-01 for Skin Aging and UV-Damaged Skin

VANCOUVER, BRITISH COLUMBIA: Phase 1 clinical trial investigating the use of a patient-specific cell-based dermal rejuvenation product (RCS-01) is scheduled to deliver data in late 2016 ...

Online Disruptive Technologies Announces Approval to Perform Diagnostic Clinical Trials on Human Blood

LAS VEGAS, NEVADA: ...

Novimmune Abstract Selected for the "Best of ASH" at the 2015 Annual Meeting of the American Society of Hematology (ASH)

GENEVA, SWITZERLAND: The Abstract Presented Data on NI-0501, an Experimental Drug for the Treatment of Hemophagocytic Lymphohistiocytosis (HLH) ...

M Pharmaceutical Announces Change to Board of Directors and Management

VANCOUVER, BRITISH COLUMBIA: ...

Medifocus, Inc. Announces Closing of First Tranche of Units Offering

COLUMBIA, MD and TORONTO, ON: ...

Entolimod Shown to Suppress Liver Metastases in Model of Ocular Melanoma in Collaborative Study by Cleveland BioLabs, Emory University and Roswell Park Cancer Institute

BUFFALO, NY: ...

Prima BioMed Progresses Japanese Collaboration

SYDNEY, AUSTRALIA: New Material Transfer Agreement (MTA) Concluded With Yamaguchi University and NEC Corporation Parties Have Combined a Cancer Vaccine With Prima's IMP321 Antigen Presenting Cell (APC) Activator Pr ...

Titan Pharmaceuticals and Braeburn Pharmaceuticals Announce Date of FDA Advisory Committee Review of Probuphine for Opioid Addiction

SOUTH SAN FRANCISCO, CA: ...

BioNeutra Global Corporation Lists on the TSX Venture Exchange

EDMONTON, ALBERTA: ...

Miraculins Announces Unsecured Non-Convertible Loans

WINNIPEG, MANITOBA: ...